Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

ClinicalTrials.gov ID: NCT03292900

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03292900. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the effectiveness of the use of a patient's genes to predict which hypertension therapy is successful

Study identification

NCT ID: NCT03292900
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Geneticure, LLC; Industry
Enrollment: 758 participants

Conditions and interventions

Conditions

Hypertension

Interventions

Not listed

Eligibility (public fields only)

Age range: 30 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 1, 2018 (Actual)
Primary completion: Dec 15, 2018 (Actual)
Completion: Jan 15, 2019 (Actual)
Last update posted: Feb 15, 2019

2018 – 2019

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Fairview Clinic - New Brighton	New Brighton	Minnesota	55112	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03292900, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 15, 2019 · Synced Nov 12, 2026